Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Sesen Bio (SESN) stocks in Canada
Learn how to easily invest in Sesen Bio stocks.
Sesen Bio is a biotechnology business based in the US. Sesen Bio stocks (SESN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.92 – a decrease of 14.11% over the previous week. Sesen Bio employs 35 staff and has a trailing 12-month revenue of around $26.5 million.
How to buy stocks in Sesen Bio
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SESN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Sesen Bio?
- Has coronavirus impacted Sesen Bio shares?
- Sesen Bio shares summary
- Compare share dealing platforms
- Is Sesen Bio stock a buy or sell?
- Sesen Bio performance over time
- Sesen Bio's financials
- How volatile are Sesen Bio shares?
- Does Sesen Bio pay a dividend?
- Other common questions
Sesen Bio stock price (NASDAQ:SESN)Use our graph to track the performance of SESN stocks over time.
Sesen Bio shares at a glance
|Latest market close||$0.41|
|52-week range||$0.37 - $5.03|
|50-day moving average||$0.56|
|200-day moving average||$1.02|
|Wall St. target price||$1.78|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.00|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Sesen Bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sesen Bio price performance over time
|1 week (2022-05-11)||0.98%|
|1 month (2022-04-14)||-18.41%|
|3 months (2022-02-14)||-39.63%|
|6 months (2021-11-18)||-59.81%|
|1 year (2021-05-18)||-84.44%|
|2 years (2020-05-15)||-38.77%|
|3 years (2019-05-17)||1.44|
|5 years (2017-05-17)||1.52|
Sesen Bio financials
|Revenue TTM||$26.5 million|
|Gross profit TTM||$1.2 million|
|Return on assets TTM||-9.68%|
|Return on equity TTM||-0.41%|
|Market capitalisation||$81.6 million|
TTM: trailing 12 months
Sesen Bio share dividends
We're not expecting Sesen Bio to pay a dividend over the next 12 months.
Sesen Bio share price volatility
Over the last 12 months, Sesen Bio's shares have ranged in value from as little as $0.365 up to $5.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sesen Bio's is 0.6789. This would suggest that Sesen Bio's shares are less volatile than average (for this exchange).
Sesen Bio overview
Sesen Bio, Inc. , a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc.
Sesen Bio in the news
AbbVie (ABBV) Buys Option Rights to NextGen Inflammation Drug
Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates
CRISPR (CRSP) Focuses on Pipeline Amid Lack of Marketed Drugs
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
Using our proprietary algorithm, we’ve found the best blue chip stocks on the TSX, NYSE and Nasdaq based on price, performance and more.Read more…
More guides on Finder
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
How to buy ProFrac Holding Corp (PFHC) stock in Canada when it goes public
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
How to buy Wytec International (WYTC) stock in Canada when it goes public
Everything we know about the Wytec International IPO, plus information on how to buy in.
Here are some of the best stocks for inflation periods to reduce the negative impacts of inflation on your portfolio.
HSBC InvestDirect Review
Choose from many account and investment types to invest in global markets, but expect to pay high commissions with HSBC InvestDirect, which doesn’t have an app.
Our Flahmingo review tells you how to buy fractional shares of some of your favourite US companies with as little as $1.
How to buy Expeditors International of Washington stock in Canada
Steps to owning and managing EXPD stock, with 24-hour and historical pricing before you buy.
How to buy Perseus Mining stock in Canada
Steps to owning and managing PRU stock, with 24-hour and historical pricing before you buy.